✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
DP-b99 is an investigational drug.
There have been 3 clinical trials for DP-b99. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Brain Ischemia. The leading clinical trial sponsors are D-Pharm Ltd. and [disabled in preview].
Recent Clinical Trials for DP-b99
|DP-b99 in the Treatment of Acute High-risk Pancreatitis||D-Pharm Ltd.||Phase 2|
|Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke||D-Pharm Ltd.||Phase 3|
|Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke||D-Pharm Ltd.||Phase 2|